ASEAN SECTORAL INTEGRATION PROTOCOL FOR HEALTHCARE The Governments of Brunei Darussalam, the Kingdom of Cambodia, the Republic of Indonesia, the Lao People's Democratic Republic (hereinafter referred to as "Lao PDR"), Malaysia, the Union of Myanmar, the Republic of the Philippines, the Republic of Singapore, the Kingdom of Thailand and the Socialist Republic of Viet Nam, Member States of the Association of South East Asian Nations (hereinafter collectively referred to as "ASEAN" or "Member States" or singularly as "Member State"); RECALLING the Declaration of ASEAN Concord II (Bali Concord II) issued in Bali, Indonesia on 7 October 2003, pursuant to which ASEAN is committed to deepen and broaden its internal economic integration and linkages with the world economy to.realise an ASEAN Economic Community; DESIRING that the ASEAN Economic Community will result in ASEAN becoming a single market and production base, turning the diversity that characterises the region into opportunities and business complementation to make ASEAN a more dynamic and stronger segment of the global supply chain; NOTING that as a first step towards the realisation of the ASEAN Economic Community, the Leaders have signed the ASEAN Framework Agreement for the Integration of Priority Sectors on 30 th November 2004 in Vientiane, Lao PDR (hereinafter referred to as the "Framework Agreement"); HAVING carried out an initial round of negotiations and concluded the roadmap for the full integration of the healthcare sector in ASEAN, HAVE AGREED AS FOLLOWS: ARTICLE 1 OBJECTIVE The objective of this Protocol is to spell out measures as in the Roadmap referred to in Article 2 to be taken by Member States on a priority basis so as to enable the progressive, expeditious and systematic integration of the healthcare sector.
ARTICLE 2 MEASURES 1. The integration measures to be pursued are grouped into two broad categories, taking into account existing agreements or earlier relevant committed measures, namely: (a) (b) Common measures which cut across all priority sectors; and Specific measures that are of direct relevance to the healthcare sector. 2. All categories of measures shall be pursued in parallel. 3. SEOM may conduct additional negotiations, as and when necessary, to consider new integration measures for the sector. ARTICLE 3 EMERGENCY MEASURES 1. Article 6 of the Common Effective Preferential Tariff (CEPT) Agreement on Safeguard Measures shall be applied to this Protocol. 2. Where emergency measures are taken pursuant to this Article, immediate notice of such action shall be given to the Ministers responsible for ASEAN economic integration referred to in Article 19 of the Framework Agreement, and such action may be the subject of consultations pursuant to Article 22 of the Framework Agreement. ARTICLE 4 APPENDICES 1. The Roadmap for Integration of Healthcare Sector shall be Appendix I to this Protocol and shall form an integral part of it. The negative list in relation to the healthcare sector shall be Appendix II to this Protocol. 2. Additional measures other than those identified in the Appendix I may be introduced, as and when deemed necessary through an amendment pursuant to paragraph 2 of Article 5 of this Protocol.
ARTICLE 5 FINAL PROVISIONS 1. Member States shall undertake the appropriate measures to fulfill the agreed obligations arising from this Protocol. 2. The provisions of this Protocol may be modified through amendments mutually agreed upon in writing by all Member States. 3. This Protocol shall enter into force on 31 August 2005. Notwithstanding the specified date of entry into force, Member States undertake to carry out the obligations which arise prior to the date of entry into force of this Protocol in accordance with the timelines indicated in the Framework Agreement for the Integration of Priority Sectors and the Roadmap for Integration of Healthcare Sector attached to this Protocol. 4. This Protocol shall be deposited with the Secretary-General of ASEAN, who shall furnish a certified copy to each Member State. IN WITNESS WHEREOF, the undersigned, being duly authorised thereto by their respective Governments, have signed the ASEAN Sectoral Integration Protocol for Healthcare. DONE at Vientiane, Lao PDR on 29 November 2004, in a single copy in the English language.
For the Government of Brunei'Darussalam overnment m of Cam ABDUL RAHMAN TAIB Minister of Industry and Primary Resources CHAM PRASIDH Senior Minister Minister of Commerce For the Government of the Republic of Indonesia For the Government of the Lao People's Democratic Republic PA^GESTU Minister of Trade SOULIVONG DARAVONG Minister of Commerce For the Government of Malaysia For the Government of the Union ofjmyanrra lirfiste^otinternational Trade and Industry THA Minister of National Planning and Economic Development For the Government of the Republic of the Philippines For the Government of the Republic of Singapore CES IMA Secretary of Trade and Industry LIM HNG KIANG Minister for Trade and Industry For the Government of the Kingdom of Thailand For the Gove/nmeprof the Socialist\Rep/blkTof Vietnam WATANA MUANGSOOK Minister of Commerce TRUONG(plNH TUYEN Minister of Trade
APPENDIX I ROADMAP FOR INTEGRATION OF HEALTHCARE SECTOR I. OBJECTIVES The objectives of this initiative are to: Strengthen regional integration through liberalisation and facilitation measures in the area of trade in goods, services and investments; and Promote private sector participation. II. MEASURES The initiatives within incorporate recommendations in the Bali Concord II as well as those gathered from private and public sector representatives from all ASEAN countries. Full implementation of these recommendations is key for ASEAN to achieve our goal of integrating the healthcare sector by 2010. However they are not meant to be exhaustive, and ASEAN should continue to incorporate other necessary measures as and when appropriate. This roadmap includes issues specific to the Healthcare sector, as well as horizontal issues cutting across all sectors. III. COVERAGE The scope of product coverage for the healthcare sector appears as Attachment 1.
NO. MEASURES IMPLEMENTING BODY TIMELINE 1 1 Tariff Elimination Eliminate CEPT-AFTA tariffs on all identified products COMMON ISSUES Coordinating Committee on the Implementation of the CEPT Scheme for AFTA (CCCA) ASEAN 6: 2007 CLMV: 2012 II 2 3 4 5 Non-Tariff Measures (NTMs) Establish the Database of ASEAN NTMs to ensure transparency 1 Establish clear criteria to identify measures that are classified as barriers to trade Establish a clear and definitive work programme for the removal of the barriers. Adopt the WTO Agreement on Import Licensing Procedures and develop implementation guidelines appropriate for ASEAN. CCCA 30 June 2004 30 June 2005 31 December 2005 31 December 2004 III 6 Rules of Origin Improve the CEPT Rules of Origin by: making it more transparent, predictable and standardised taking into account the best practices of other Regional Trade Agreements including the rules of origin of the WTO; and - adopting substantial transformation as alternative criteria for conferring origin status. Task Force on CEPT Rules of Origin (ROO- TF) 31 December 2004 IV 7 Customs Procedures Extend the application of the ASEAN Harmonised Tariff Nomenclature (AHTN) for extra-asean trade. Expert Committee on Customs Matters (ECCM) 8 Develop a simplified, improved and harmonised customs declaration form. 31 December 2005 1 The database on ASEAN NTMs has been completed and posted in the ASEAN Website.
NO. MEASURES IMPLEMENTING BODY Ensure full implementation of the Green Lane System for CEPT Products, or similar systems, at entry points of all Member States. TIMELINE 31 December 2004 10 11 Develop implementation guidelines, as appropriate, for Member States which are not members of the WTO to fulfill the obligations of the WTO Agreement on Customs Valuation Adopt service commitment (client charter) by ASEAN customs authorities. 31 December 2004 31 December 2004 12 Develop the Single Window approach, including the electronic processing of trade documents at national and regional levels Inter-Agency Task Force on Single Window 31 December 2005 V 13 Standards and Conformance Accelerate the implementation/ development of sectoral Mutual Recognition Arrangements (MRAs), as appropriate ASEAN Consultative Committee on Standards and Quality (ACCSQ) beginning 1 January 2005 14 Encourage domestic regulators to recognise test reports issued by testing laboratories which are already accredited by National Accreditation Bodies in ASEAN that are signatories to I LAC and APLAC MRA 15 Set clear targets and schedules for harmonisation of standards, wherever required; where international standards are not available, and when requested by industry, align national standards among Member States. 31 December 2005 16 Harmonise and/or develop, wherever appropriate, technical regulations for national application. 31 December 2010 17 Ensure compliance with the requirements, rights and obligations of WTO Agreements on Technical Barriers to Trade and the Application of Sanitary and Phyto-Sanitary Measures
NO. MEASURES IMPLEMENTING BODY TIMELINE 18 Explore development of ASEAN policy on standards and conformance to further facilitate the realisation of the ASEAN Economic Community. beginning 2005 VI 19 Logistics Services Expedite the development of integrated transport logistics services within ASEAN through: Senior Transport Officials Meeting (STOM) beginning 2005 Promotion of efficient door-to-door cargo transport and cross-border transport facilitation through the expeditious implementation of the ASEAN Framework Agreement on the Facilitation of Goods in Transit, and the ASEAN Framework Agreement on Multimodal Transport; Improvement of land transport network infrastructures and services to achieve better interconnectivity, inter-operability and inter-modality with the national, regional and international maritime and air transport gateways; Strengthening intra-asean maritime and shipping transport services; and Establishment of enabling and conducive policy environment for increased private sector involvement and/or public-private partnerships in the development of transport infrastructure and the provision and operation of transport logistics facilities and services. VII 20 Outsourcing and Industrial Complementation Identify and develop specialisation of production processes, research and Working Group on Industrial Cooperation development (R&D), and testing (WGIC), with inputs facilities based on comparative from the private advantages of individual Member sector States
NO. MEASURES IMPLEMENTING BODY 21 Develop guidelines to promote outsourcing arrangements among Member States, as applicable. TIMELINE VIII ASEAN Integration System of Preferences 22 Endeavour to expand the coverage of the ASEAN Integration System of Preferences (AISP) Scheme by including products in the priority integration sectors CCCA IX 23 Investments Accelerate the opening up of sectors currently in the Sensitive List (SL) by transferring these sectors into the Temporary Exclusion List (TEL) under the Framework Agreement on the ASEAN Investment Area, using the ASEAN-X formula. Coordinating Committee on Investment (CCI) beginning 2004 24 Reduce restrictive investment measures in the SL beginning 2004 25 Complete the progressive elimination of restrictive investment measures in the TEL 26 Identify programmes and activities to promote investments in ASEAN 31 December 2005 27 Promote manufacturing processes across different ASEAN countries to take advantage of their comparative strengths through: - the establishment of a network of ASEAN free trade zones to facilitate outsourcing activities undertaking more efficient joint ASEAN facilitation and promotion measures to promote FDI beginning 2005 28 Promote and facilitate joint/cross border investments in manufacturing activities through: special incentives, where appropriate, to be given by CLMV for investments from ASEAN Timelines in accordance with AIA Agreement (ASEAN-6 = 2010; Vietnam = 2013; Cambodia, Laos and Myanmar = 2015)
NO. MEASURES IMPLEMENTING BODY TIMELINE special measures, where appropriate to be given by ASEAN 6 to promote and facilitate relocation of investment to CLMV countries especially for labour intensive manufacturing activities X 29 Trade and Investment Promotion Intensify intra- and extra ASEAN joint promotion efforts regularly CCI; ASEAN Chambers of Commerce and Industry (ASEAN- CCI); and relevant Industry Clubs/ Associations beginning 2005 30 Organise regular private sector initiatives to undertake: - more efficient joint ASEAN facilitation and promotion measures to promote FDI ASEAN selling-buying missions; and promotional activities to assist CLMV countries CCI; ASEAN Business Advisory Council (ASEAN-BAC); and ASEAN-CCI beginning 2005 31 Undertake more effective joint ASEAN facilitation in promotion measures and develop new sources of inward foreign direct investments, particularly from potential countries such as the People's Republic of China, India and the Republic of Korea XI 32 Intra-ASEAN Trade and Investment Statistics Establish an effective system to Working Group on monitor intra-asean trade and Statistics; Working investment through: Group on Foreign provision of updates to the Direct Investment ASEAN Secretariat of the latest Statistics; and CCCA trade (goods and services) and investment statistics preparation of consolidated industry profile, by the respective associations, which among other matters, cover information such as production capacity and product range
NO. MEASURES IMPLEMENTING BODY TIMELINE XII 33 Intellectual Property Rights Expand the scope of ASEAN intellectual property rights cooperation beyond trademarks and patents by including cooperation in copyrights information exchange and enforcement ASEAN Working Group on Intellectual Property Cooperation (AWGIPC) 31 December 2004 XIII 34 Trade in Services Member States shall accelerate the liberalisation of trade in services earlier than 2020. This could be achieved through: Setting clear targets and schedules of services liberalisation for each priority sector and each round towards achieving freer flow of trade in services by 2010; - Accelerating the development of Mutual Recognition Arrangements (MRAs); - The application of the ASEAN-X formula; and Promotion of joint ventures and cooperation, including in third country markets. Coordinating Committee on Services (CCS) and CCI before 2008 XIV 35 Movement of Business Persons, Skilled Labour, Talents and Professionals Develop an ASEAN Agreement to facilitate the movement of business persons, including the adoption of an Directors-General of Immigration Departments and 31 December 2005 ASEAN Travel Card, taking into Heads of Consular account Member States' domestic Affairs Division of the laws and regulations. Ministries of Foreign Affairs (DGICM) 36 Develop an ASEAN Agreement to facilitate the movement of experts, professionals, skilled labor and talents, taking into account Member States' domestic laws and regulations CCS 31 December 2005 37 Accelerate completion of MRAs to facilitate free movement of experts, professionals, skilled labor and talents in ASEAN, taking into account Member States' domestic laws and regulations 31 December 2008
NO. XV 38 39 MEASURES Facilitation of Travel in ASEAN Harmonise procedures for the issuance of visas to international travelers Provide visa exemption for intra- ASEAN travel by ASEAN nationals IMPLEMENTING BODY TIMELINE DGICM 31 December 2004 2005 XVI 40 Human Resource Development Develop and upgrade skills and capacity building through joint trainings and workshops. Senior Labour Officials Meeting (SLOM) XVII 41 SPECIFIC ISSUES Investments Allow higher share of ASEAN ownership / participation in selected healthcare establishments, subject to domestic laws and regulations of each ASEAN country, on an ASEAN- X basis CCS and CCI 42 Set up "one-stop centre" in each ASEAN country responsible for facilitating investments, including healthcare projects CCI 31 December 2008 XVIII 43 Standards and Conformity Pharmaceutical Products Study the feasibility of an ASEAN Mutual Recognition Arrangement (MRA) for pharmaceutical / medicinal products ACCSQ Pharmaceutical Product Working Group (PPWG) 30 December 2005 44 Implement the ASEAN Common Technical Dossier 31 December 2008 45 Harmonise the labelling standards for pharmaceutical/medicinal products 31 December 2006 46 Explore the feasibility of adopting a harmonised placement system for pharmaceutical / medicinal products into the ASEAN markets 31 December 2009 47 To facilitate the approval process, the ASEAN-X formula can be applied. The recognition of the approval process can only be realised when Member States fully implement the ACTD after 31 December 2008
NO. MEASURES IMPLEMENTING BODY 48 Explore the feasibility of implementing a flexible twinning system, where member states voluntarily pair with one or other member states to cooperate in enhancing mutual regulatory capacity and resource development TIMELINE 49 Formalise a post-marketing alert system for defective and unsafe pharmaceutical/medicinal products. 31 December 2005 50 Cosmetics Accelerate implementation of the ASEAN Harmonised Cosmetic Regulatory Scheme (AHCRS), and automatic listing for cosmetics products ACCSQ ASEAN Cosmetics Committee (ACC) 1 January 2008 51 Formalise a post-marketing alert system for defective or unsafe cosmetic products 31 December 2005 Medical Device and Equipment 52 Medical Device and Equipment Working Group to look into integration measures, which includes the following: Developing a common submission dossier template for product approval in ASEAN Exploring the feasibility of an abridged approval process for medical devices which regulators of benchmarked countries or recognised regional regulators have approved Exploring the feasibility of adopting of a harmonised system of placement of medical devices into the ASEAN markets based on a common product approval process Formalising of a post-marketing alert system for defective or unsafe medical devices or equipment - All ASEAN countries to consider joining the Asian Harmonisation Work Party (AHWP) and work in ACCSQ Medical Device and Equipment Working Group beginning 2005
NO. MEASURES IMPLEMENTING BODY TIMELINE parallel with the Global Harmonisation Task Force (GHTF) on technical harmonisation efforts 53 54 55 56 57 Traditional Medicines and Health Supplements Exchange, review and analyse ACCSQ Traditional information on the existing regulatory framework/regime including standard Medicines and Health Supplements Working definition, terminologies, and Group (TMHSWG) technical infrastructure in Member Countries Identify areas for possible harmonisation and MRAs Study the existing regulatory frameworks/regime of selected countries and internationally accepted technical guidelines Enhance the technical infrastructure including mutual confidence in testing and conformity assessment Formalisation of a post-marketing alert system for unsafe traditional medicine or health supplements 31 December 2006 31 December 2009 31 December 2006 2004 onwards 31 December 2007 XIX 58 Capacity Building More established ASEAN countries to provide training and host attachment programmes for medical and healthrelated workers from less developed ASEAN member states. Relevant ASEAN Professional Associations, e.g., ASEAN Association of Radiologists 59 Provide more exchanges and training for medical and health-related professionals from less developed member states. This is especially necessary for areas of key shortages like specialists and skilled operators of medical equipment MRI and CT scanners 60 To strengthen cooperation within ASEAN countries in the area of capacity building, i.e., exchange of experts, regulatory infrastructure and human resource development, within available resources ACCSQ 10
NO. MEASURES IMPLEMENTING BODY TIMELINE 61 Member states to consider modelling their technical standards and regulations after ASEAN harmonised technical standards and regulations which is to be evolved from acceptable international or regional technical standards and regulations. This lowers the cost of setting up regulations and is a step towards harmonisation of regulations within ASEAN XX 62 Movement of Patients Minimise visa requirements for intra- ASEAN travel by ASEAN nationals to facilitate cross border movement of patients and accompanying persons CCS and DGICM 31 December 2005 11
No 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 I 16"" 1 17 18 19 20 AHTN 1211.10.10 1211.10.90 1211.20.10 1211.20.90 1211.30.10 1211.30.90 1211.90.11 1211.90.12 1211.90.13 1211.90.19 1211.90.91 1211.90.92 1211.90.93 1211.90.94 1211.90.95 1211.90.99 2936.10.00 2936.21.00 2936.22.00 2936.23.00 Attachment I Coverage of the Healthcare Products Sector Description "" " '" 1 - - Cut, crushed or powdered form - - Cut, crushed or powdered form - - Cut,.crushed or powdered form --Other Cannabis, in cut, crushed or powdered form Cannabis, other form Other, in cut, crushed or powdered form ---Othdr Pyrethrum, in cut, crushed or powdered form Pyrethrum, other form.. Cannabis Sandalwood... ' Gaharu wood chips - - Provitamins, unmixed - - Vitamins A and their derivatives - - Vitamin B1 and its derivatives -- Vitamin B2 and its derivatives 21 2936.24.00 - - D- or DL-Pantothenic acid (Vitamin B3 or Vitamin B5) and its derivatives 22 23^ 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 2936.25.00 2936.26.00 2936.27.00 2936.28.00 2936.29.00 2936.90.00 2937.12.00 2937.19.00 2937.21.00 2937.22.00 2937.23.00 2937.29.00 2937.31.00 2937.39.00 2937.40.00 2937.50.00 3001.10.00 3001.20.00 3001.90.00 3002.10.10 3002.10.20 3002.10.90 3002.20.10 3002.20.20 3002.20.90 - - Vitamin B6 and its derivatives -- Vitamin B1 2 and its derivatives, ' " - - Vitamin C and its derivatives - - Vitamin E and its derivatives -- Other vitamins and their derivatives - Other, including natural concentrates -- Insulin and its salts --Other - - Cortisone, hydrocortisone, prednisone (dehydrocortisone) and prednisolone (dehydrohydrocortisone) - - Halocjenated derivatives of corticosteroidal hormones - - Oestrogens and progestogens - - Epinephrine - Amino-acid derivatives - Prostaglandis, thromboxanes and leukotrienes, their derivatives and structural analogues - Glands and other organs, dried, whether or not powdered - Extracts of glands or other organs or of their secretions - Other - - Plasma protein solution - - Antisera and modified immunological products whether or not obtained by means of biotechnological processes - - Tetanus toxoid - - Pertusis, measles, meningitis A/C, and polio vaccine Page 1 of 6
Attachment I Coverage of the Healthcare Products Sector No 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 AHTN 3002.30.00 3002.90.00 3003.10.10 3003.10.20 3003.10.90 3003.20.00 3003.31.00 3003.39.00 3003.40.10 3003.40.90 3003.90.10 3003.90.20 3003.90.30 3003.90.40 3003.90.90 3004.10.11 3004.10.12 3004.10.13 3004.10.14 3004.10.19 3004.10.21 3004.10.29 3004.20.11 3004.20.12 3004.20.19 3004.20.21 3004.20.22 3004.20.29 3004.20.31 3004.20.32 3004.20.39 3004.20.41 3004.20.42 3004.20.43 3004.20.49 3004.20.51 3004.20.52 3004.20.59 3004.20.60 3004.20.90 3004.31.00 3004.32.10 3004.32.20 3004.32.30 3004.32.90 3004.39.10 3004.39.90 Description - Vaccines for veterinary medicine - Other - - Containing amoxicillin (INN) or its salts - - Containing ampicillin (INN) or its salts - Containing other antibiotics - - Containing insulin - - Antimalarial - - Containing vitamins - - Containing analgesics or antipyretics, whether or not containing antihistamines preparations for the treatment of coughs and colds, whether or not containing antihistamines - - Antimalarial Containing penicillin G or its salts (excluding penicillin G benzathin) Containing phenoxymethyl penicillin or its salts Containing ampicillin or its salts, for taking orally Containing amoxycillin or its salts, for taking orally - Ointment - For taking orally Ointment - For taking orally Ointment - For taking orally Ointment - Containing gentamycines or derivatives thereof, for injection Containing lincomycins or derivatives thereof, for taking orally Ointments - For taking orally - - - Ointments - - - Containing isoniazide, pyrazinamide or derivatives thereof, for taking orally - - Containing insulin Containing hydrocortisone sodium succinate Containing dexamethasone or its derivatives Containing fluocinolone acetonide - Containing adrenaline - Page 2 of 6
No 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 i 113~1 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 AHTN 3004.40.10 3004.40.20 3004.40.30 3004.40.40 3004.40.50 3004.40.60 3004.40.70 3004.40.90 3004.50.10 3004.50.20 3004.50.30 3004.50.40 3004.50.50 3004.50.60 3004.50.71 3004.50.79 3004.50.90 r 3004.90.10 ^3004.90.21 3004.90.22 3004.90.23 3004.90.29 3004.90.30 3004.90.41 3004.90.49 3004.90.51 3004.90.52 3004.90.53 3004.90.54 3004.90.59 3004.90.61 3004.90.62 3004.90.69 3004.90.71 3004.90.72 3004.90.79 3004.90.80 3004.90.91 3004.90.92 3004.90.93 3004.90.94 3004.90.95 3004.90.96 Attachment I Coverage of the Healthcare Products Sector Description - - Containing morphine or its derivatives, for injection - - Containing quinine hydrochloride or dihydrochloride, for injection - - Containing quinine sulphate or bisulphate, for taking orally - - Containing quinine or its salts and anti-malaria substances, other than goods of subheadings 3004.10 to 30 - - Containing papaverine or berberine - - Containing theophylline - - Containing atropin sulphate - - Syrups and drops of vitamins, of a kind suitable for children - - Containing vitamins A, other than goods of subheading 3004.50.10 - - Containing vitamins B1 or B2 or B6 or B12, other than goods of subheadings 3004.50.10 and 3004.50.20 - - Containing vitamins C, other than goods of subheadings 3004.50.10, 3004.40.20 and 3004.50.30 - - Containing vitamins PP, other than goods of subheadings 3004.50.10, 3004.50.20,3004.50.30 and 3004.50.40 - - Containing other vitamins, other than goods of subheadings 3004.50.10, 3004.50.20, 3004.50.30, 3004.50.40 and 3004.50.50 Containing B complex vitamins - - - Specialised medicines for cancer, AIDS or other intractable diseases Sodium chloride solution 5% glucose solution 30% glucose solution - - - Antiseptics Containing procaine hydrochloride - Containing acetylsalicylic acid, paracetamol or dipyrone (INN) Containing chlorpheniramine maleate Containing diclofenac Analgesic balm oil, solid or liquid - Containing artemisinin, artesunate or chloroquine (INN) Containing primaquine - Containing piperazine or mebendazole (INN) Containing dichlorophen (INN) - - - Transdermal therapeutic systems (ITS) patches for cancer or heart diseases Containing sulpiride (INN), cimetidine (INN), ranitidine (INN), aluminium hydroxide or magnesium hydroxide or orezol Containing piroxicam (INN) or ibuprofen (INN) Containing phenobarbital, diazepam, chlorpromazine Containing salbutamol (INN) Closed sterile water for inhalation, pharmaceutical grade Containing o-methoxyphenyl glyceryl ether (Guaifenesin) Page 3 of 6
No 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 16<T 167 168 169 170 171 172 173 174 175 176 177 178 179 AHTN 3004.90.97 3004.90.98 3004.90.99 3005.10.10 3005.10.90 3005.90.10 3005.90.20 3005.90.30 3005.90.90 3006.10.00 3006.20.00 3006.30.10 3006.30.20 3006.30.30 3006.30.90 3006.40.10 3006.40.20 3006.50.00 3006.60.00 3006.70.00 3006.80.00 3303.00.00 3304.10.00 3304.20.00 3304.30.00 3304.91.00 3304.99.10 3304.99.20 3304.99.90 3305.10.10 3305.10.90 3305.20.00 3305.30.00 3305.90.10 3305.90.90 3306.10.10 3306.10.90 3306.20.00 3306.90.00 3307.10.00 3307.20.00 3307.30.00 3307.41.10 Attachment I Coverage of the Healthcare Products Sector Description Nose-drop medicaments containing naphazoline, xylometazoline or oxymetazoline - - - Sorbitol - - - Covered or impregnated with pharmaceutical substances - - Bandages - - Gauze - - Gamgee - Sterile surgical catgut, similar sterile suture materials and sterile tissue adhesives for surgical wound closure; sterile laminaria and sterile laminaria tents; sterile absorbable surgical or dental haemostatics - Blood-grouping reagents - - Barium sulfate (for taking orally) - - Reagents of microbial origin for veterinary biological diagnosis microbial diagnostic reagents - - Dental cements and other dental fillings - - Bone reconstruction cements - First-aid boxes and kits - Chemical contraceptive preparations based on hormones, on other products of heading 29.37 or on spermicides - Gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments - Waste Pharmaceuticals Perfumes and toilet waters. - Lip make-up preparations - Eye make-up preparations - Manicure or pedicure preparations - - Powders, whether or not compressed Face and skin creams and lotions Anti-acne creams - - - Anti-mycosis shampoos - Preparations for permanent waving or straightening - Hair lacquers - - Brilliantines and other hair oils - - Prophylactic pastes and powders - Yarn used to clean between the teeth (dental floss) - Other - Pre-shave, shaving or after-shave preparations - Personal deodorants and antiperspirants - Perfumed bath salts and other bath preparations Scented joss sticks Page 4 of 6
Attachment I Coverage of the Healthcare Products Sector No 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 AHTN 3307.41.90 3307.49.10 3307.49.90 3307.90.10 3307.90.20 3307.90.30 3307.90.90 3401.11.10 3401.11.20 3401.11.30 3401.11.90 3401.19.10 3401.19.90 3401.20.10 3401.20.20 3401.20.90 3401.30.00 4014.10.00 4818.40.10 4818.40.20 4818.50.10 4818.50.90 5208.21.10 6307.90.20 6307.90.90 8419.20.00 8713.10.00 8714.20.11 8714.20.12 8714.20.19 8714.20.20 8714.20.30 8714.20.90 9001.30.00 9018.11.00 9018.12.00 9018.13.00 9018.14.00 9018.19.00 9018.20.00 9018.31.10 Description - Room perfuming preparations - - - Animal toilet preparations; other perfumery or cosmetics, including depilatories - - Contact lens solution - - Papers and tissues, impregnated or coated with perfume or cosmetics Medicated products Bath soap Other, of felt or nonwovens, impregnated, coated or covered with soap or detergent - Of felt or nonwovens, impregnated, coated or covered with soap or detergent - - - For flotation de-inking of recycled paper - - Soap chips - Organic surface-active products and preparations for washing the skin, in the form of liquid or cream and put up for retail sale, whether or not containing soap - Sheath contraceptives - - Napkins and napkin liners for babies and similar sanitary articles - - Sanitary towels, tampons and similar articles - - Surgical face masks Absorbent fabric for surgical use - - Surgical face masks - Medical, surgical or laboratory sterilisers - Not mechanically propelled Of a diameter (including tyres) exceeding 75 mm but not exceeding 100 mm provided that the width of the wheel or tyre fitted thereto is not less than 30mm Of a diameter (including tyres) exceeding 100 mm but not exceeding 250 mm provided that the width of the wheel or tyre fitted thereto is not less than 30 mm - - - Spokes - - Nipples - Contact lenses - - Electro-cardiographs - - Ultrasonic scanning apparatus - - Magnetic resonance imaging apparatus - - Scintigraphic apparatus - Ultra-violet or infra-red ray apparatus Disposable syringes Page 5 of 6
No 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 AHTN 9018.31.90 9018.32.00 9018.39.10 9018.39.20 9018.39.90 9019.10.10 9019.10.90 9019.20.10 9019.20.90 9021.10.00 9021.29.00 9021.31.00 9021.39.00 9021.40.00 9021.50.00 9021.90.00 9022.12.00 9022.13.00 9022.14.00 9022.19.10 9022.19.90 9022.21.00 9022.29.00 9402.90.10 9402.90.90 Attachment I Coverage of the Healthcare Products Sector Description - - - Tubular metal needles and needles for sutures Catheters Disposable tubes for intravenous fluids - - - Electronic - - Artificial respiration apparatus - Orthopaedic or fracture appliances - - Artificial joints - Hearing aids, excluding parts and accessories - Pacemakers for stimulating heart muscles, excluding parts and accessories - Other - - Computed tomography apparatus, for dental use, for medical, surgical, or veterinary uses X-ray apparatus for the physical inspection of solder joints on PCB/PWB assemblies - - - For medical, surgical, dental or veterinary uses - - For other uses - - Furniture specially designed for medical, surgical or veterinary surgical purposes and parts thereof Page 6 of 6
41 No 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 Appendix II Negative List of ASEAN Member Countries for Healthcare Products Sector AHTN 3304.10.00 t 3304.20.00 [ 3304.30.00 i 3304.91.00 3304.99.10 3304.99.20 3304.99.90 3305.10.10 3305.10.90 3305.20.00 3307.10.00 3307.20.00 1 - Personal deodorants and antiperspirants 3307.30.00 - Perfumed bath salts and other bath preparations 3307.49.10 Room perfuming preparations 3401.11.10 Medicated products 3401. 11. 201 Bath soap 3401.11.90, - 3401.19.90-3401.20.10 - - For flotation de-inking of recycled paper 3401.20.90 - Other 3401.30.00 8419.20.00 Description - Lip make-up preparations - Eye make-up preparations - Manicure or pedicure preparations - - Powders, whether or not compressed Face and skin creams and lotions Anti-acne creams ---Other - - Anti-mycosis shampoos f - Preparations for permanent waving or straightening - Pre-shave, shaving or after-shave preparations - Organic surface-active products and preparations for washing the skin, in the form of liquid or cream and put up for retail sale, whether or not containing soap - Medical, surgical or laboratory sterilisers No 1 2 3 4 5 6 7 8 9 10 ~'11" 12 13 14 is 16 17 18 19 20 ^^ *^^^^^^^^^^^^^^^ AHTN 3304.10.00 1 3304.91.00 3304.99.10 ; 3305.10.10 { 3305.10.90 3305.30.00 1 I 3305.90.10! 3305.90.90, 1 3306.10.10 ' i 3306.10.90 I 3306.90.00 3307.10.00 3307.20.00 3307.41.10 3307.41.90 3307.49.10 3307.49.90 ' 3401.11.10 3401.11.20 3401.11.90 Description - Lip make-up preparations - - Powders, whether or not compressed Face and skin creams and lotions - - Anti-mycosis shampoos - Hair lacquers - - Brilliantines and other hair oils - - Prophylactic pastes and powders --Other ; _..._._,_...,:. - Other - Pre-shave, shaving or after-shave preparations - Personal deodorants and antiperspirants Scented joss sticks ---Other Room perfuming preparations ---Other Medicated products Bath soap ---Other ~ " " " " Page 1 of 7
Appendix II Negative List of ASEAN Member Countries for Healthcare Products Sector 21 3401.19.10 Of felt or nonwovens, impregnated, coated or covered with soap or detergent 22 23 24 25 26 27 28 29 3401.19.90 :---Other _ 3401.20.90 ]--Other -.--.- - 4818.50.90 [--Other ~" "" "~"~ 6307.90.90 ] : -Other]" J 7 I!" ~ 1LZ 8419.20.00 - Medical, surgical or laboratory sterilisers 9019.10.90 T-- Other!- - Furniture specially designed for medical, surgical or veterinary surgical 9402.90.10 ipurposes and parts thereof 9402.90.90 : --Other No 1 2" 3 AHTN 1211.30.10 1211.30.90 1211.90.11 1211.90.12 -I! 5 1211.90.93 Description j- - Cut, crushed or powdered form F-Other!- - - Cannabis, in cut, crushed or powdered form f- -_- Cannabjs, other form I Cannabis No 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 AHTN 3303.00.00 3304.10.00 i 3304.20.00 330430.00 3304.91.00 3304.99.10 3304.99.20 3304.99.90 3305.10.10 3305.10.90 3305.20.00 3305.30.00 3305.90.10 3305.90.90 3307.49.10 ; 3307.90.10 i Description Perfumes and toilet waters. - Lip make-up preparations - Eye make-up preparations - Manicure or pedicure preparations - - Powders, whether or not compressed Face and skin creams and lotions Anti-acne creams l - - - Anti-rnycosis shampoos "~ - Preparations for permanent waving or straightening - Hair lacquers - - Briiliantines and other hair oils Room perfuming preparations - - Animal toilet preparations; other perfumery or cosmetics, including depilatories No AHTN Description 1 3304.91.00,- - Powders, whether or not compressed 2! 3305.10.10 i--anti-mycosis shampoos 3 3305.10.90!--Other F _ 7~ I I 4 : 3305.20.00 \- Preparations for permanent waving or straightening 5, 3305.30.00 \- Hair lacquers 6 ; 3305.90.10 '-- Briiliantines and other hair oils 7 i 3305.90.90 '--Other ' '_ ----- -------- 8 3306.10.90 --Other ~~ ~" "~ " Page 2 of 7
Appendix II Negative List of ASEAN Member Countries for Healthcare Products Sector 9 10 11._._.._ 13 3306.20.00 3307.49.90 3307.90.10 3307.90.20 3307.90.90 - Yarn used to clean between the teeth (dental floss) ---Other "."."I" Z ~."~~..~ "~ -^.-.--^...-..- - - Animal toilet preparations; other perfumery or cosmetics, including depilatories - - Contact lens solution No 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 Wi^^W«**j * i " - K, AHTN t 1211.30.10 1211.30.90 1211.90.11 1211.90.12 1211.90.93 1211.90.95 3001.10.00 300 1.90. 00 ~ 3002.90.00 3003.40.90 3003.90.90 3004.10.21 3004.20.11 3004.20.12 3004.20.21 3004.20.22" 3004.20.31 j 3004.20.32 3004.20.42 3004.20.43 3004.20.51 3004.20.52 1 3004.20.90 3004.32.30 3004.40.50 3004.40.90 3004.50.50 3004.50.60 3004.50.90 3004.90.23 3004.90.41 3004.90.54 3004.90.59 3004.90.71 3004.90.72 3004.90.80 3006.30.90 3303.00.00.^.^. % : -^ii*«:<- - --;.*-.'.. M van mar,.-...'. ",.,X,....,.-.'!'. '..':_.>,.,;;,.,,,5 Description - - Cut, crushed or powdered form L Cannabis, in cut, crushed or powdered form Cannabis, other form Cannabis Gaharu wood chips - Glands and other organs, dried, whether or not powdered -Other - Other L - Other Ointment For taking orally Ointment For taking orally -I Ointment For taking orally Ointment Containing lincomycins or derivatives thereof, for taking orally Ointments - - - For taking orally Ointments Containing fluocinolone acetonide - - Containing papaverine or berberine - - Containing vitamins PP, other than goods of subheadings 3004.50.10, 3004.50.20,3004.50.30 and 3004.50.40 - - Containing other vitamins, other than goods of subheadings 3004.50.10, 3004.50.20, 3004.50.30, 3004.50.40 and 3004.50.50 30% glucose solution Containing procaine hydrochloride Analgesic balm oil, solid or liquid "--"-Other" Containing piperazine or mebendazole (INN) Containing dichlorophen (INN) - - Transdermal therapeutic systems (ITS) patches for cancer or heart diseases --Other Perfumes and toilet waters. Page 3 of 7
Appendix II Negative List of ASEAN Member Countries for Healthcare Products Sector 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 3304.91.00 3304.99.10 1 3305.10.10 3305.90.10 3306.10.10 3306.10.90 3307.10.00 3307.20.00 ; 3307.41.10-3307.41.90 3401.11.10 3401.11.20 3401.11.30 I ; 3401.11.90 6307.90.90 L 9001.30.00 9018.31.10 9018.31.90 9019.10.90 9402.90.90 - - Powders, whether or not compressed Face and skin creams and lotions - - Anti-mycosis shampoos I- - Brilliantines and other hair oils - - Prophylactic pastes and powders - Pre-shave, shaving or after-shave preparations - Personal deodorants and antiperspirants Scented joss sticks ;- I Medicated products Bath soap -, of felt or nonwovens, impregnated, coated or covered with soap or detergent j^- Other I^Other - Contact lenses Disposable syringes - l ' No 1...?.. 3."" 4 5 ~ 6 7 8 9 AHTN 3401.11.10 3401.11.20 3401.11.30 "1 3401.11790 3401.19.10 3401/19.90 3401.20.20 ' 3401.20.90 "i' j 3401.30.00 '^ Htf *1^^ s^joliil * ^' "^ ' ^^j^^f^1 ^'^^'^^,p^^^^^p^t^^;' s s''-"^'^i^^?^^p^^^^^ Description Medicated products Bath soap i Other, of feit or nonwovens, impregnated, coated or covered with soap or detergent ---Other """ """ Of felt or nonwovens, impregnated, coated or covered with soap or detergent ---Other :- - Soap chips --Other - Organic surface-active products and preparations for washing the skin, in the ;form of liquid or cream and put up for retail sale, whether or not containing soap i I PW^ Nu 1 2 3 4 5 6 7 8 9 10 AHTN 3004.10.19 3004.10.21 3004.10.29 : 3004.20.11 j 3004.20.12 3004.20.2i : 3004.20.22 3004.20.31 i 3004.20.39 I 3004.20.41 i Description!--- Other Ointment ;--- Other " _~~.~_'^'.i.. "".....""_...... For taking orally - - - Ointment - - For taking orally Ointment i- - - For taking orally -~ v - Other '. \ ZiriZ_Z"_l.!.r..-"V.~'J"~LL"..'... Containing gentamycines or derivatives thereof, for injection Page 4 of 7
Appendix II Negative List of ASEAN Member Countries for Healthcare Products Sector 11! 3004.20.42 Containing lincomycins or derivatives thereof, for taking orally 12 T 3004.20.43T Ointments _ " ~ Z Z ZZ ISZ 3004.20.49"Z """ ZZ ZZZZ" ZZ'ZZZZ ZIZZZZ 14 [ 3004.20.51 - - - For taking orally 15 j 3004.20.52 j- - - Ointments _ 16 73004.20.59l---Other ^ ~ ZZZZZ""" ZZ1 _ZZZ.ZZZ" Z.Z.ZZZZZZZZZZ 17 3004.20.60 i- - Containing isoniazide, pyrazinamide or derivatives thereof, for taking orally 18 Z3004.20.90 --Other 19 j 3004.32.10 Containing hydrocortisone sodium succinate 20 3004.32.30!-_-- Containing fluocinolone acetpnide 21 ; 3004.39.10 [---Containing adrenaline 2Y1 3004.39.90 V Other Z ZZZ ZZZZZZZ.ZZZZ 23 3004.40.10 - - Containing morphine or its derivatives, for injection 24 3004.40.50 '- - Containing papaverine or berberine "25 Z 3004.40.90 ZL-Other Z ZZ _ 26 r 3004.50.79" - Other ~ ZZ 27^" Z 3004.50.9CT"[- -jdther ZZZZ ZZ.ZZZZZZZZZIZZ." 28! 3004.90.21! Sodium chloride solution 29 I 3004.90.22 ]-_--5% glucose solution^ _ ^ 3004.90.23 Z-Z 30% g^cose _ s M9 n _ Z " 31 } 3004.90.29 i-"-"-other" Z _Z" II^l ^L ] Z 32!"3004.9049 i---other 33 i 3004.90.52 ; Containing chlprpheniramine maleate 34! 3004.90.53 J---Containing diclofenac '"" '~~_ 35 i 3004.90.54 j Analgesic balm oil, solid or liquid 36Z 3004.90.59 7- \~~_'~~~^L 37 3004.90.71 I Containing piperazine or mebendazole (INN) 38" r 3004.90.72!- - - Containing dichlorophen (INN) ZZ 39 7 3004.90.79 J--"- Other Z " ZZZZ^."ZZZ Z~ "JZZ ZZ.ZZ."Z Z.Z. ^nn4 Qn Q1 Containing sulpiride (INN), cimetidine (INN), ranitidine (INN), aluminium j ' ' :hydroxide or magnesium hydroxide or orezo[ 41 I 3004.90.92 -_- - Containing piroxicam (inn) or ibuprofen (]NN) ZZZZ_I - 42 1 3004.90.93 [ Containing phenobarbital, diazepam, chlorpromazine 43 [3004.90.95 [---Closed sterile water for inhalation, pharmaceutical grade _ 44 J_3004.90.96 j- - -Containing o-methoxyphenyl glyceryl ether (Guaifenesin) 45 Nose-drop medicaments containing naphazoline, xylometazoline or 3004.90.97 ioxymetazoline 46 i 3004.90.99 i - Z.ZZ ZI Z Z' -..1 Z T 47 ] 3303.00.00 Perfumes and toilet waters. ^ ^ 48 i 3304.10.00!- Lip make-up preparations 49 3304.20.00 j - Eye make-up preparations _ 50 ; 3304.30.00 - Manicure or pedicure preparations 51 i 3304.91.00 :- - Powders, whethsr or not compressed 52 3304.99.10 ; Face and skin creams and lotions 53 ; 3304.99.20 r--anti-acne creams 54 3304.99.90 t---other Z 55 3305.10.10 ;- -Anti-mycosis shampoos 56Z 3305.1090 i--other "~ " 57 3305.20.00 j-preparations for permanent waving or straightening 58 i 3305.30.00!-Hair lacquers _ 59 j 3305.90.10 r - Srilliantines and" other h'air oils ' " Page 5 of 7
60 61 62 63 64 65 "66" 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87" 88 89 90 Appendix II Negative List of ASEAN Member Countries for Healthcare Products Sector 3305.90.90 3306.10.10 - - Prophylactic pastes and powders 3306.10.90 ' j 3306.90.00" r - Other i 3307.10.00^ r - Pre-shave, shaving or after-shave preparations 3307.20.00 - Personal deodorants and antiperspirants ' 3307.30.00 ; 3307.41.10 1 3307.41.90" 3307.49.10 3307.49.90 3307.90.10 3307 90.20 "330790.30 3307.90.90 3401.11.10 3401.11.20 3401.11.30 ^3401.11 90 i 3401.19.10 3401.19.90 - ""3401.20.16 - - For flotation de-inking of recycled paper 3401. 20.20' - - Soap chips 3401.20.90 --Other "! 3401.30.00 i 4818.40.10 T 48 18.40.20 : 4818.50.10 1 f 4818.50.90 i S402.9C.10. 79402.90^90[ - Perfumed bath salts and other bath preparations Scented joss sticks - Room perfuming preparations - - - Animal toilet preparations; other perfumery or cosmetics, including depilatories - - Contact lens solution - - Papers and tissues, impregnated or coated with perfume or cosmetics Medicated products Bath soap Other, of felt or nonwovens, impregnated, coated or covered with soap or detergent - Of felt or nonwovens, impregnated, coated or covered with soap or detergent - Organic surface-active products and preparations for washing the skin, in the form of liquid or cream and put up for retail sale, whether or not containing soap - - Napkins and napkin liners for babies arid similar sanitary articles - - Sanitary towels, tampons and similar articles - - Surgical face masks - - Furniture specially designed for medical, surgical or veterinary surgical purposes and paris thereof a, i* Mo 1 2 3 4 5 6 7 8 9 10 AHTN i 3003.10.10 ' 3003.10.20 3004.10.11 3004.10.12 3004.10.13 3004.10.14 3004.20.11 3004.20.12 ' "3004.20.21 [3004.20.22 Description - - Containing amoxicillin (INN) or its salts - - Containing ampicillin (INN) or its salts Containing penicillin G or its salts (excluding penicillin G benzathin) Containing phenoxymethyl penicillin or its salts Containing ampicillin or its salts, for taking orally Containing amoxycillin or its salts, for taking orally - - - For taking orally Ointment For taking orally Ointment : ^:; Page 6 of 7
19 20 21 22 Appendix II Negative List of ASEAN Member Countries for Healthcare Products Sector 11 3004.20.31 ---Fortaking orally 12 3004.20.32 --- Ointment 13 3004.20.41 f- - - Containing gentamycines or derivatives thereof, for injection 14 3004.20.42 J Containing lincomycins or derivatives thereof, for taking orally 15 3004.20.43 j- - - Ointments s ; 3004.20.51 [---For taking orally ; 3004.20.52 - - - Ointments.. -_.. 3004.20.60 - - Containing isoniazide, pyrazinamide or derivatives thereof, for taking orally 3004.32.30 j--- Containing fluocinolone acetonide 3004.50.20!- - Containing vitamins A, other than goods of subheading 3004.50.10 3004.50.30 3004.50.40 j- - Containing vitamins B1 or B2 or B6 or B12, other than goods of subheadings [3004.50.10 and 3004.50.20 - - Containing vitamins C, other than goods of subheadings 3004.50.10, [3004.40.20 and 3004.50.30 23~; 3004.50.79 J^ - Other." JI~ri_~l_J.1_. ~~ "" "._ 24, 3004.90.21 ]-- -Sodium chloride solution '_'" """_ 25 3004.90.22!- - - 5% glucose solution 26 [ 3004,90.23 \- -- 30% glucose solution '_~~1_ "_ ~~_ ~^~ 27 3004.90.51 j Containing acetylsalicylic acid, paracetamol or dipyrone (INN) 28 i 3004.90.52!--- Containing chlorpheniramine maleate 29! 3004.90.53 T- -- Containing diclofenac 30 3004.90.54 [---Analgesic balm oil, solid or liquid _ 31 3004.90.62 Containing primaquine 32. 3004.90.71 i Containing piperazine or mebendazole (INN) Q [ Containing sulpiride (INN), cimetidine (INN), ranitidine (INN), aluminium : ' _'"! hydroxide or magnesium hydroxide or orezol 34 j_ 3004.90.92 [ Containing piroxicarn (INN) or ibuprofen (INN) _ a- i Nose-drop medicaments containing naphazoline, xylometazoline or. v? /,,. loxymetazolme 36 : 3005.10.10 j- - Covered or impregnated with pharmaceutical substances 37~"j 3005.90/JO" :-"- Bandages 38! 3005.90.20 ] Gauze ' "" '""_'_ ^ ^ _""_"_". ---.- ^ 1 ---. - ----- 39 j 3005.90.30 j--garngee_ ~" ~ ^ ~^ ~ 40 1^3005.90.90 J-- Other "" ~~~_~ ~T 1 "_" ~II~ " ~_ 41 5208.21.10 I Absorbent fabric for surgical use Page 7 of 7